Literature DB >> 18588534

The role of gamma-synuclein in cocaine-induced behaviour in rats.

Frederic Boyer1, Jean-Luc Dreyer.   

Abstract

The aim of this study was to investigate the role of gamma-synuclein in the rewarding effects of chronic cocaine administration and its putative interaction with the dopamine transporter (DAT). For this purpose, regulatable lentiviruses driving overexpression of the rat gamma-synuclein or DAT have been prepared, as well as lentiviruses expressing siRNAs, aimed at silencing either DAT or gamma-synuclein mRNA expression. Overexpression of DAT in the nucleus accumbens (NAc) induced a 35% decrease in locomotor activity, which could be abolished when the same animal was fed doxycycline. Furthermore, local inhibition of DAT in the NAc, using lentiviruses expressing siRNAs targeted against DAT, resulted in significant hyperlocomotion activity (72% increase over controls). By contrast, overexpression of gamma-synuclein in the NAc alone had no effect, while local silencing lead to a significant decrease in cocaine-induced locomotor activity (47% decrease compared with controls). Surprisingly, coinjection lentiviruses expressing DAT and gamma-synuclein - leading to overexpression of both proteins in the NAc - resulted in a strong increase in cocaine-induced rat locomotor activity (52% increase compared with controls), which was abolished upon locally silencing these genes, suggesting a synergetic role of both proteins, possibly mediated through a direct interaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18588534     DOI: 10.1111/j.1460-9568.2008.06198.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

1.  Viral-mediated knockdown of mGluR7 in the nucleus accumbens mediates excessive alcohol drinking and increased ethanol-elicited conditioned place preference in rats.

Authors:  Amine Bahi
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

Review 2.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

3.  No effect of sex on ethanol intake and preference after dopamine transporter (DAT) knockdown in adult mice.

Authors:  Amine Bahi; Jean-Luc Dreyer
Journal:  Psychopharmacology (Berl)       Date:  2018-12-12       Impact factor: 4.530

Review 4.  Synuclein modulation of monoamine transporters.

Authors:  Adam W Oaks; Anita Sidhu
Journal:  FEBS Lett       Date:  2011-03-23       Impact factor: 4.124

5.  Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward.

Authors:  Danielle L Graham; Vaishnav Krishnan; Erin B Larson; Ami Graham; Scott Edwards; Ryan K Bachtell; Diana Simmons; Lana M Gent; Olivier Berton; Carlos A Bolanos; Ralph J DiLeone; Luis F Parada; Eric J Nestler; David W Self
Journal:  Biol Psychiatry       Date:  2008-11-06       Impact factor: 13.382

6.  Cocaine-induced locomotor activity in rats selectively bred for low and high voluntary running behavior.

Authors:  Jacob D Brown; Caroline L Green; Ian M Arthur; Frank W Booth; Dennis K Miller
Journal:  Psychopharmacology (Berl)       Date:  2014-08-09       Impact factor: 4.530

7.  Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats.

Authors:  Omar Abdul-Rahman; Maria Sasvari-Szekely; Agota Ver; Klara Rosta; Bernadett K Szasz; Eva Kereszturi; Gergely Keszler
Journal:  BMC Genomics       Date:  2012-02-27       Impact factor: 3.969

8.  Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice.

Authors:  Rubén Pavia-Collado; Raquel Rodríguez-Aller; Diana Alarcón-Arís; Lluís Miquel-Rio; Esther Ruiz-Bronchal; Verónica Paz; Leticia Campa; Mireia Galofré; Véronique Sgambato; Analia Bortolozzi
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.